Breast Cancer, Colon Cancer, Lung Cancer, Neuroblastoma, Testicular Cancer
Conditions
Keywords
Quality of Life, Focus groups, Risks of Ionizing Radiation, Risk of medical imaging, 11-185
Brief summary
Risks from imaging-related radiation exposure have become a popular topic in the media. Because these tests are commonly applied to patients at a cancer center, it is important to understand what patients know, how they feel about what they know, where they get their information, and how satisfied they are with available risk-benefit communication on this topic. The purpose of this study is to understand how cancer patients perceive risks and benefits of diagnostic radiation and their satisfaction with healthcare communication on this topic.
Interventions
Participants will complete a pre-focus group demographic questionnaire. Focus group participants will be asked to report the following: current age; gender; race/ethnicity; income; highest education attained; occupation; and cancer stage if participant has a cancer history. Participants who are parents of pediatric patients will also report their child's current age, gender, and cancer stage. Ten questions will be developed by the investigators and posed to each group by the moderator to solicit the desired information. The objective for the focus groups will be to systematically explore three domains: 1) what participants know about radiation as it relates to medical imaging; 2) how what they know or believe about radiation shapes their attitudes about it; 3) and participant perceptions regarding the availability and adequacy of their sources, including risk-benefit communication with health care providers
Sponsors
Study design
Eligibility
Inclusion criteria
* English-language fluent * 18 years of age, or older * Provide informed consent * Group 1: Patients undergoing chemotherapy for Stage IV colorectal carcinoma. * Group 2: Parents of pediatric patients who have undergone treatment for stage 1-3 neuroblastoma. * Group 3: Women who have undergone treatment for early stage breast cancer within the preceding 6 months. * Group 4: Men undergoing surveillance imaging after treatment for testicular cancer. * Group 5: Patients currently or previously enrolled in the MSKCC lung cancer screening program. * Group 6: Patients enrolled in or eligible for the thoracic survivorship program.
Exclusion criteria
* Participants who don't speak English
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| characterize participant knowledge, attitudes | 2 years | about imaging radiation, information sources, and satisfaction with risk-benefit communication. |
Countries
United States